Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.341
+0.013 (3.91%)
At close: Mar 9, 2026, 4:00 PM EDT
0.349
+0.009 (2.58%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Silo Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 4 | 4 | 11 | 14 | 36 | |
| Market Cap Growth | -32.32% | -10.63% | -57.65% | -24.99% | -61.09% | 339.46% | |
| Enterprise Value | -1 | -4 | -4 | -2 | 3 | 34 | |
| Last Close Price | 0.34 | 0.89 | 1.44 | 3.36 | 7.13 | 21.22 | |
| PE Ratio | - | - | - | - | 5.63 | - | |
| PS Ratio | 62.90 | 55.35 | 61.94 | 146.27 | 197.31 | - | |
| PB Ratio | 0.71 | 0.79 | 0.72 | 1.02 | 1.55 | 28.22 | |
| P/TBV Ratio | 0.95 | 0.83 | 0.72 | 1.02 | 1.55 | 28.22 | |
| EV/Sales Ratio | - | - | - | - | 41.81 | - | |
| Debt / Equity Ratio | - | - | - | - | - | 0.02 | |
| Net Debt / Equity Ratio | -1.17 | -1.41 | -1.24 | -1.10 | -1.13 | -0.87 | |
| Net Debt / EBITDA Ratio | 1.11 | 1.51 | - | - | - | - | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | |
| Quick Ratio | 8.29 | 4.28 | 9.88 | 26.06 | 20.93 | 7.96 | |
| Current Ratio | 8.70 | 4.29 | 9.90 | 26.52 | 21.23 | 10.07 | |
| Return on Equity (ROE) | -86.11% | -78.37% | -43.97% | -40.28% | 80.38% | -321.66% | |
| Return on Assets (ROA) | -44.37% | -38.80% | -24.86% | -20.60% | -30.34% | -132.54% | |
| Return on Invested Capital (ROIC) | - | - | - | - | - | -833.13% | |
| Return on Capital Employed (ROCE) | -93.50% | -81.80% | -55.30% | -32.50% | -28.90% | -158.50% | |
| Earnings Yield | -111.95% | -110.06% | -82.86% | -37.06% | 27.76% | -8.41% | |
| Buyback Yield / Dilution | -87.67% | -19.50% | -34.83% | -19.07% | -45.44% | -181.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.